Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
65
CZWI Quote, Financials, Valuation and Earnings
Last price:
$15.04
Seasonality move
:
0.85%
Day range:
$14.84 - $15.08
52-week range:
$11.72 - $17.04
Dividend yield:
2.39%
P/E ratio:
11.94x
P/S ratio:
2.76x
P/B ratio:
0.83x
Volume:
27.8K
Avg. volume:
85.8K
1-year change:
20.18%
Market cap:
$150.2M
Revenue:
$56.3M
EPS (TTM):
$1.26
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $68.4M | $69.7M | $67.2M | $58.5M | $56.3M | |
| Revenue Growth (YoY) | 21.45% | 1.89% | -3.58% | -12.88% | -3.84% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $23.8M | $24.3M | $23.6M | $22.7M | $24.3M | |
| Other Inc / (Exp) | $542K | $1.2M | $541K | $459K | -$856K | |
| Operating Expenses | $26M | $25.9M | $25.1M | $23.4M | $25M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $17.3M | $29M | $23.6M | $18.9M | $17.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $4.6M | $7.7M | $5.8M | $5.9M | $3.7M | |
| Net Income to Company | $12.7M | $21.3M | $17.8M | $13.1M | $13.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $12.7M | $21.3M | $17.8M | $13.1M | $13.8M | |
| Basic EPS (Cont. Ops) | $1.14 | $1.98 | $1.69 | $1.25 | $1.34 | |
| Diluted EPS (Cont. Ops) | $1.14 | $1.98 | $1.69 | $1.25 | $1.34 | |
| Weighted Average Basic Share | $11.2M | $10.7M | $10.5M | $10.5M | $10.3M | |
| Weighted Average Diluted Share | $11.2M | $10.7M | $10.5M | $10.5M | $10.3M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $31.6M | $39.3M | $36.6M | $54.8M | $60.6M | |
| Revenue (Reported) | $68.4M | $69.7M | $67.2M | $58.5M | $56.3M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $31.6M | $39.3M | $36.6M | $54.8M | $60.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $17.1M | $15.9M | $15.1M | $15.2M | $14.2M | |
| Revenue Growth (YoY) | 4.38% | -6.86% | -4.85% | 0.35% | -6.5% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $5.9M | $5.7M | $5.7M | $5.9M | $6M | |
| Other Inc / (Exp) | $235K | -$37K | $56K | $167K | $10K | |
| Operating Expenses | $6.3M | $6.1M | $5.9M | $6M | $6.1M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $7.5M | $6.2M | $4.9M | $5.2M | $4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.9M | $1.5M | $1.3M | $1.1M | $777K | |
| Net Income to Company | $5.5M | $4.7M | $3.7M | $4.1M | $3.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $5.5M | $4.7M | $3.7M | $4.1M | $3.2M | |
| Basic EPS (Cont. Ops) | $0.50 | $0.45 | $0.35 | $0.39 | $0.32 | |
| Diluted EPS (Cont. Ops) | $0.50 | $0.45 | $0.35 | $0.39 | $0.32 | |
| Weighted Average Basic Share | $11M | $10.5M | $10.5M | $10.4M | $10M | |
| Weighted Average Diluted Share | $11M | $10.5M | $10.5M | $10.4M | $10M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $10.3M | $8.4M | $11.8M | $16M | $13.5M | |
| Revenue (Reported) | $17.1M | $15.9M | $15.1M | $15.2M | $14.2M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $10.3M | $8.4M | $11.8M | $16M | $13.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $69.1M | $68.5M | $66.4M | $58.6M | $55.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $24M | $24.1M | $23.6M | $22.8M | $24.4M | |
| Other Inc / (Exp) | $704K | $953K | $634K | $570K | -$1M | |
| Operating Expenses | $26.1M | $25.7M | $24.8M | $23.6M | $25.2M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $21.2M | $27.7M | $22.3M | $19.2M | $16.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $5.6M | $7.3M | $5.6M | $5.7M | $3.4M | |
| Net Income to Company | $15.6M | $20.5M | $16.7M | $13.5M | $12.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $15.6M | $20.5M | $16.7M | $13.5M | $12.9M | |
| Basic EPS (Cont. Ops) | $1.41 | $1.94 | $1.59 | $1.29 | $1.26 | |
| Diluted EPS (Cont. Ops) | $1.41 | $1.94 | $1.59 | $1.29 | $1.26 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $34.1M | $37.4M | $40M | $59M | $58.1M | |
| Revenue (Reported) | $69.1M | $68.5M | $66.4M | $58.6M | $55.3M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $34.1M | $37.4M | $40M | $59M | $58.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $17.1M | $15.9M | $15.1M | $15.2M | $14.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $5.9M | $5.7M | $5.7M | $5.9M | $6M | |
| Other Inc / (Exp) | $235K | -$37K | $56K | $167K | $10K | |
| Operating Expenses | $6.3M | $6.1M | $5.9M | $6M | $6.1M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $7.5M | $6.2M | $4.9M | $5.2M | $4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.9M | $1.5M | $1.3M | $1.1M | $777K | |
| Net Income to Company | $5.5M | $4.7M | $3.7M | $4.1M | $3.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $5.5M | $4.7M | $3.7M | $4.1M | $3.2M | |
| Basic EPS (Cont. Ops) | $0.50 | $0.45 | $0.35 | $0.39 | $0.32 | |
| Diluted EPS (Cont. Ops) | $0.50 | $0.45 | $0.35 | $0.39 | $0.32 | |
| Weighted Average Basic Share | $11M | $10.5M | $10.5M | $10.4M | $10M | |
| Weighted Average Diluted Share | $11M | $10.5M | $10.5M | $10.4M | $10M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $10.3M | $8.4M | $11.8M | $16M | $13.5M | |
| Revenue (Reported) | $17.1M | $15.9M | $15.1M | $15.2M | $14.2M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $10.3M | $8.4M | $11.8M | $16M | $13.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $123.2M | $49.2M | $35.6M | $37.1M | $50.2M | |
| Short Term Investments | -- | $140K | -- | $73.5M | $72.9M | |
| Accounts Receivable, Net | $5.7M | $3.9M | $5.3M | $5.4M | $5.7M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $128.8M | $53.3M | $40.9M | $116M | $128.7M | |
| Property Plant And Equipment | $21.2M | $21.2M | $20.5M | $18.4M | $17.1M | |
| Long-Term Investments | $202.9M | $290.8M | $266.7M | $253M | $236M | |
| Goodwill | $31.5M | $31.5M | $31.5M | $31.5M | $31.5M | |
| Other Intangibles | $8.7M | $8.1M | $6.7M | $5.6M | $4.6M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.6B | $1.7B | $1.8B | $1.9B | $1.7B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | -- | |
| Long-Term Debt | $181.8M | $170M | $214.9M | $147M | $66.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.5B | $1.6B | $1.6B | $1.7B | $1.6B | |
| Common Stock | $111K | $105K | $104K | $104K | $100K | |
| Other Common Equity Adj | $1.5M | $161K | -$17.7M | -$17.3M | -$16.4M | |
| Common Equity | $160.6M | $170.9M | $167.1M | $173.3M | $179.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $160.6M | $170.9M | $167.1M | $173.3M | $179.1M | |
| Total Liabilities and Equity | $1.6B | $1.7B | $1.8B | $1.9B | $1.7B | |
| Cash and Short Terms | $123.2M | $49.3M | $35.6M | $110.6M | $123M | |
| Total Debt | $181.8M | $170M | $214.9M | $147M | $66.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $198.1M | $85.9M | $65.3M | $28.6M | $100.2M | |
| Short Term Investments | $185.2M | $187.9M | -- | $2.5M | $70.8M | |
| Accounts Receivable, Net | $5.5M | $4.2M | $5.6M | $6.3M | $5.9M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $388.7M | $278M | $70.8M | $37.5M | $177M | |
| Property Plant And Equipment | $21.1M | $21.4M | $20.2M | $18M | $16.6M | |
| Long-Term Investments | $257.9M | $309.2M | $288.3M | $257.9M | $232.3M | |
| Goodwill | $31.5M | $31.5M | $31.5M | $31.5M | $31.5M | |
| Other Intangibles | $9.1M | $8.1M | $6.4M | $5.3M | $4.4M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.7B | $1.8B | $1.9B | $1.8B | $1.8B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | -- | |
| Long-Term Debt | $173.8M | $172.6M | $249.8M | $107M | $61.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.6B | $1.6B | $1.7B | $1.6B | $1.6B | |
| Common Stock | $109K | $105K | $105K | $104K | $100K | |
| Other Common Equity Adj | $1M | -$7M | -$16.6M | -$18M | -$15M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $160.7M | $165.5M | $164.6M | $172.8M | $180.1M | |
| Total Liabilities and Equity | $1.7B | $1.8B | $1.9B | $1.8B | $1.8B | |
| Cash and Short Terms | $383.2M | $273.8M | $65.3M | $31.1M | $171M | |
| Total Debt | $173.8M | $172.6M | $249.8M | $107M | $61.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $12.7M | $21.3M | $17.8M | $13.1M | $13.8M | |
| Depreciation & Amoritzation | $6.6M | $4M | $4M | $3.7M | $3.4M | |
| Stock-Based Compensation | $14K | $8K | $3K | -- | -- | |
| Change in Accounts Receivable | -$1.8M | $1.2M | $79K | $54K | -$1.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $23.8M | $21.6M | $29.3M | $13.1M | $20.2M | |
| Capital Expenditures | $2.6M | $3.8M | $3.6M | $1.4M | $889K | |
| Cash Acquisitions | $1.1M | -- | -- | -- | -- | |
| Cash From Investing | -$61.8M | -$163.2M | -$119.2M | -$34.2M | $113.7M | |
| Dividends Paid (Ex Special Dividend) | -$2.4M | -$2.5M | -$2.7M | -$3M | -$3.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $81.2M | -- | $146.2M | $25M | -- | |
| Long-Term Debt Repaid | -$74M | -$12.1M | -$101.6M | -$93.2M | -$80.6M | |
| Repurchase of Common Stock | -$2.8M | -$8M | -$1.9M | -$550K | -$6.2M | |
| Other Financing Activities | $118K | $127K | $401K | $223K | $224K | |
| Cash From Financing | $101.6M | $69.9M | $77.6M | $22.9M | -$120.9M | |
| Beginning Cash (CF) | $55.8M | $119.4M | $47.7M | $35.4M | $37.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $63.6M | -$71.7M | -$12.3M | $1.8M | $13M | |
| Ending Cash (CF) | $119.4M | $47.7M | $35.4M | $37.1M | $50.2M | |
| Levered Free Cash Flow | $21.2M | $17.8M | $25.7M | $11.8M | $19.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $5.5M | $4.7M | $3.7M | $4.1M | $3.2M | |
| Depreciation & Amoritzation | $479K | $645K | $968K | $888K | $845K | |
| Stock-Based Compensation | $3K | $1K | -- | $158K | $68K | |
| Change in Accounts Receivable | $322K | $410K | -$837K | -$966K | $37K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $13.5M | $8.9M | $1.8M | $9.1M | $1.6M | |
| Capital Expenditures | $462K | $797K | $313K | $214K | $100K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$8.7M | -$12.3M | -$15.9M | $18M | $21.7M | |
| Dividends Paid (Ex Special Dividend) | -$2.5M | -$2.7M | -$3M | -$3.3M | -$3.6M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $34.2M | -- | -- | -- | |
| Long-Term Debt Repaid | -$8.1M | -$31.6M | -$35.2M | -$5.5M | -$5M | |
| Repurchase of Common Stock | -$2.6M | -$429K | -$129K | -$711K | -$183K | |
| Other Financing Activities | $26K | $44K | $58K | -- | -- | |
| Cash From Financing | $71.8M | $40.2M | $43.8M | -$35.7M | $26.8M | |
| Beginning Cash (CF) | $119.4M | $47.7M | $35.4M | $37.1M | $50.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $76.6M | $36.7M | $29.7M | -$8.5M | $50M | |
| Ending Cash (CF) | $196M | $84.4M | $65.1M | $28.6M | $100.2M | |
| Levered Free Cash Flow | $13.1M | $8.1M | $1.5M | $8.9M | $1.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $15.6M | $20.5M | $16.7M | $13.5M | $12.9M | |
| Depreciation & Amoritzation | $6.2M | $4.2M | $4.4M | $3.7M | $3.4M | |
| Stock-Based Compensation | $13K | $6K | $2K | $158K | -$90K | |
| Change in Accounts Receivable | -$2.6M | $1.3M | -$1.2M | -$75K | -$772K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $28.1M | $16.9M | $22.2M | $20.5M | $12.6M | |
| Capital Expenditures | $2.6M | $4.1M | $3.1M | $1.3M | $775K | |
| Cash Acquisitions | $1.1M | -- | -- | -- | -- | |
| Cash From Investing | -$74.1M | -$166.9M | -$122.8M | -$230K | $117.4M | |
| Dividends Paid (Ex Special Dividend) | -$2.5M | -$2.7M | -$3M | -$3.3M | -$3.6M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $23.7M | $34.2M | $112M | -- | -- | |
| Long-Term Debt Repaid | -$17.1M | -$35.6M | -$105.2M | -$63.5M | -$80.1M | |
| Repurchase of Common Stock | -$3.6M | -$5.8M | -$1.6M | -$1.1M | -$5.7M | |
| Other Financing Activities | $128K | $145K | $415K | $223K | -- | |
| Cash From Financing | $200.7M | $38.3M | $81.2M | -$56.6M | -$58.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $154.7M | -$111.7M | -$19.3M | -$36.4M | $71.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $25.4M | $12.8M | $19.1M | $19.2M | $11.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $5.5M | $4.7M | $3.7M | $4.1M | $3.2M | |
| Depreciation & Amoritzation | $479K | $645K | $968K | $888K | $845K | |
| Stock-Based Compensation | $3K | $1K | -- | $158K | $68K | |
| Change in Accounts Receivable | $322K | $410K | -$837K | -$966K | $37K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $13.5M | $8.9M | $1.8M | $9.1M | $1.6M | |
| Capital Expenditures | $462K | $797K | $313K | $214K | $100K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$8.7M | -$12.3M | -$15.9M | $18M | $21.7M | |
| Dividends Paid (Ex Special Dividend) | -$2.5M | -$2.7M | -$3M | -$3.3M | -$3.6M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $34.2M | -- | -- | -- | |
| Long-Term Debt Repaid | -$8.1M | -$31.6M | -$35.2M | -$5.5M | -$5M | |
| Repurchase of Common Stock | -$2.6M | -$429K | -$129K | -$711K | -$183K | |
| Other Financing Activities | $26K | $44K | $58K | -- | -- | |
| Cash From Financing | $71.8M | $40.2M | $43.8M | -$35.7M | $26.8M | |
| Beginning Cash (CF) | $119.4M | $47.7M | $35.4M | $37.1M | $50.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $76.6M | $36.7M | $29.7M | -$8.5M | $50M | |
| Ending Cash (CF) | $196M | $84.4M | $65.1M | $28.6M | $100.2M | |
| Levered Free Cash Flow | $13.1M | $8.1M | $1.5M | $8.9M | $1.5M | |
Get CZWI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CZWI
Sector
P/E ratio
11.94x
12.21x
PEG ratio
1.77x
0.40x
P/B ratio
0.83x
1.11x
Price / LTM sales
2.76x
2.66x
Growth Metrics
CZWI
Sector
Revenue growth
-6.5%
5.12%
Earnings growth
-17.95%
2.63%
Revenue (5-year growth)
-0.01%
5.17%
Earnings forecast
$0.29
$0.61
Profitability
CZWI
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
4.95%
5.21%
Return on assets
0.72%
0.97%
Return on equity
7.24%
9.24%
Earnings Date
Last Earnings Date
Apr
28
Next Earnings Date
Jul
29
Estimated Next Earnings Date
Jul
28
Balance Sheet
CZWI
Sector
Total cash
$171M
$451.2M
Short term investments
$72.9M
$220.9M
Total assets
$1.7B
$3.8B
Long term debt
$61.7M
$280.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
